Amanote Research
Register
Sign In
Higher Bleeding Rates in Patients Taking Rivaroxaban Following an Embolic Stroke of Undetermined Source
Journal of Pharmacy Practice and Research
- United States
doi 10.1002/jppr.1572
Full Text
Open PDF
Abstract
Available in
full text
Categories
Pharmacology
Pharmacy
Date
May 29, 2019
Authors
Yassar Alamri
Publisher
Wiley
Related search
Efficacy and Safety of Rivaroxaban Versus Aspirin in Embolic Stroke of Undetermined Source and Carotid Atherosclerosis
Journal of Vascular Surgery
Surgery
Cardiovascular Medicine
Cardiology
Embolic Stroke of Undetermined Source in a Young Woman
American Journal of Hematology
Hematology
Frequency and Features of Embolic Stroke of Undetermined Source in Young Adults
European Stroke Journal
Neurology
Cardiovascular Medicine
Cardiology
NAVIGATE ESUS: Phase-Iii RCT Assessing Prevention of Stroke and Systemic Embolism in Patients With Embolic Stroke of Undetermined Source
Journal of the Neurological Sciences
Neurology
Pulmonary Arteriovenous Malformation Can Be Associated With Embolic Stroke of Undetermined Source (ESUS)
European Journal of Case Reports in Internal Medicine
Internal Medicine
Association Between Left Ventricular Ejection Fraction, Wall Motion Abnormality, and Embolic Stroke of Undetermined Source
Journal of the American Heart Association
Cardiovascular Medicine
Cardiology
Relationship Between Lambl’s Excrescences and Embolic Strokes of Undetermined Source
European Stroke Journal
Neurology
Cardiovascular Medicine
Cardiology
Diagnostic Considerations of Embolic Strokes of Undetermined Source on Admission
Neurosonology
Arterial Stiffness and Indices of Left Ventricular Diastolic Dysfunction in Patients With Embolic Stroke of Undetermined Etiology
Disease Markers
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Genetics